Salvianolic acid b

3 papers5 findings

PubChem 6451084 ChEBI 134301 MeSH C076944

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

2 independent labs in 1 country

Funders: National Natural Science Foundation of China and 1 more

Animals1
Cells1

Outcomes

Cellular senescence

downin human cells2

2 studies

Salvianolic acid b decreases cellular senescence in human cells.
“SAB effectively alleviates the cellular senescence phenotype.”
Cellsin aging fibroblasts (BJ)
Salvianolic acid B attenuates cellular senescence and age-related decline in muscle function via dual mTOR/TP53INP2-autophagy regulation
Frontiers in chemistry5 Mar 2026
Salvianolic acid b inhibits cellular senescence in human cells.
“effectively suppressed HCMV-induced cellular senescence”
Cellsin HCMV-infected WI-38 cells
Inhibitory effect of three components derived from Salvia miltiorrhiza against human cytomegalovirus
Virology journal2 Mar 2026